Filter
1175
Filtered Results: 1175
Text search:
rifampicin
Featured
Recommendations
138
New Publications
296
Language
Document type
No document type
745
Guidelines
175
Studies & Reports
107
Manuals
65
Strategic & Response Plan
31
Training Material
20
Fact sheets
20
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
61
Western and Central Europe
60
Eastern Europe
36
South Africa
28
Nepal
27
Latin America and the Carribbean
22
Kenya
21
Argentina
19
Colombia
16
Nigeria
16
Tanzania
16
Peru
15
Global
14
Paraguay
14
Uganda
14
Namibia
14
Ethiopia
14
Germany
13
Bangladesh
13
Zambia
13
Indonesia
13
Rwanda
12
Malawi
12
El Salvador
11
Senegal
11
Myanmar / Burma
11
Ukraine
10
Philippines
10
Bolivia
10
Brazil
10
South–East Asia Region
9
Mozambique
8
Cambodia
8
Asia
8
Congo, Democratic Republic of
8
Russia
7
Cameroon
6
Africa
6
Tajikistan
5
Benin
5
Zimbabwe
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Ghana
4
Chile
4
Burkina Faso
4
Venezuela
4
Botswana
4
Liberia
4
Lesotho
3
Haiti
3
Georgia
3
Bhutan
3
Madagascar
3
Pakistan
3
Timor Leste/ East Timor
2
Sierra Leone
2
Syria
2
Armenia
2
Jordan
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Central African Republic
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Guinea
1
USA
1
Dominican Republic
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Tunisia
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
461
Clinical Guidelines
145
Women & Child Health
25
Public Health
23
Capacity Building
16
Pharmacy & Technologies
14
Key Resources
9
Toolboxes
TB
537
HIV
106
NTDs
68
AMR
44
Pharmacy
42
Refugee
18
Polio
13
COVID-19
9
Ebola & Marburg
8
Caregiver
6
Conflict
5
Mental Health
4
Global Health Education
3
Rapid Response
2
Natural Hazards
2
Planetary Health
1
NCDs
1
Zika
1
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
Глобальными приоритетами для лечения туберкулеза (ТБ) и борьбы с ним являются улучшенное и ранее выявление случаев туберкулеза, в том числе случаев заболевания с о...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
Автоматизированная технология амплификации нуклеиновых кислот в режиме реального времени для быстрого и одновременного выявления туберкулеза и устойчивости к р...
La publicación describe el funcionamiento del método rápido, confiable, sencillo y económico al laboratorio que permita examinar un gran número de muestras a fin de seleccionar a aquellos pacientes que pudieran estar potencialmente infectados con Mycobacterium tuberculosis multirresistente a lo...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation...
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed TB resistant isoniazid (INH). Drug resistance must be detected rapidly and accurately to initiate appr...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
